Top compounds associated with response to BZW1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.003
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA avicin D CTRPv2 pan-cancer AAC 0.16 0.004
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.11 0.005
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.098 0.005
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.1 0.005
mRNA Gemcitabine gCSI pan-cancer AAC 0.16 0.005
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.16 0.005
Download CSV